Stay updated on A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    No additions or deletions detected on the page; the content appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:48:09.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    3%
    Check dated 2025-10-05T08:58:14.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Page revision updated to v3.1.0 and new contact number 502-562-3429 added; previous revision v3.0.2 removed.
    Difference
    0.1%
    Check dated 2025-09-28T03:03:50.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Updated page revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' link, a minor UI change with no substantive content changes.
    Difference
    0.2%
    Check dated 2025-09-13T16:58:45.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.2%
    Check dated 2025-09-06T14:35:45.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to skin and connective tissue diseases and specific proteins. Notably, the revision number has changed from v2.16.12 to v3.0.0.
    Difference
    2%
    Check dated 2025-08-30T11:23:10.000Z thumbnail image

Stay in the know with updates to A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial page.